JITF Infra Logistics will see Dr. Raj Kamal Aggarwal, Mr. Girish Sharma, and Mr. Dhananjaya Pati Tripathi cease to be independent directors on September 4, 2026. The departures follow the completion of their second consecutive five-year terms on the board.

The company disclosed the change pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed with the BSE and NSE on September 2, 2026.

Director Tenure Details

All three directors completed their tenure at the close of working hours on September 4, 2026. The company confirmed that each individual served a second term of five consecutive years in the independent director role.

The filing included Annexure A as required under SEBI Circular no. SEBI/HO/CFD/CFD-POD-1/P/CIR/2023/123 dated July 13, 2023. No relationships between the directors were disclosed in the filing.

JITF Infralogistics appointed Dr. Vinita Jha as an additional independent woman director effective Sept 2, 2026. The board also accepted the resignation of Ms. Kanika Sharma, a non-executive director, with immediate effect.

The changes were approved during a board meeting held on Sept 2, 2026, in New Delhi. The session commenced at 2:00 pm and concluded at 2:30 pm. Dr. Jha’s appointment aims to strengthen the board’s diversity and governance framework.

Board Composition Changes

Dr. Vinita Jha joins the company with a decade of senior leadership experience in corporate hospitals and healthcare operations. Her professional background includes roles at Max Health Care and Somerset Partnership NHS Trust in the UK. She holds an MBBS degree, an MBA from Cardiff University, and a CCT in Psychiatry from the UK.

Ms. Kanika Sharma stepped down from her position as a non-executive woman director. She cited a transition from current responsibilities as the reason for her resignation. She also ceased membership from all board committees on which she served.

The company confirmed that there are no inter-se relationships between Dr. Jha and other board members. Dr. Jha is not debarred from holding office by SEBI or any other authority.

Regulatory Disclosure

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified both the BSE Limited and the National Stock Exchange Limited of these developments. Alok Kumar, Company Secretary, signed the communication.